Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Climb Bio (CLYM) Other Non Operating Income (2020 - 2026)

Climb Bio filings provide 7 years of Other Non Operating Income readings, the most recent being -$25000.0 for Q1 2026.

  • Quarterly Other Non Operating Income rose 50.0% to -$25000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$266000.0 through Mar 2026, down 103.28% year-over-year, with the annual reading at -$291000.0 for FY2025, 103.58% down from the prior year.
  • Other Non Operating Income hit -$25000.0 in Q1 2026 for Climb Bio, up from -$46000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $8.1 million in Q4 2024 and bottomed at -$934000.0 in Q3 2022.
  • Average Other Non Operating Income over 5 years is $830000.0, with a median of -$2000.0 recorded in 2024.
  • The largest annual shift saw Other Non Operating Income soared 1034.18% in 2022 before it crashed 8000.0% in 2025.
  • Climb Bio's Other Non Operating Income stood at $1.8 million in 2022, then fell by 17.35% to $1.5 million in 2023, then surged by 447.33% to $8.1 million in 2024, then tumbled by 100.57% to -$46000.0 in 2025, then soared by 45.65% to -$25000.0 in 2026.
  • Per Business Quant, the three most recent readings for CLYM's Other Non Operating Income are -$25000.0 (Q1 2026), -$46000.0 (Q4 2025), and -$33000.0 (Q3 2025).